Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein.
about
Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin DrugsSafety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A.Prolonged prophylactic protection from botulism with a single adenovirus treatment promoting serum expression of a VHH-based antitoxin protein.Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B.Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin EA three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes.Use of Monoclonal Antibodies in the Sensitive Detection and Neutralization of Botulinum Neurotoxin Serotype B.Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparations.Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E.Potential therapeutic roles for antibody mixtures.A Novel Rabbit Spirometry Model of Type E Botulism and its Use for the Evaluation of Post-symptom Antitoxin Efficacy.A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes.An ambient temperature-stable antitoxin of nine co-formulated antibodies for botulism caused by serotypes A, B and E.
P2860
Q26863621-793DD92D-124B-4C79-97B6-364A886E5360Q34057328-4AD091D4-E615-486F-9C48-1351E0936301Q34110625-79159C35-6258-4F84-8010-0EC92260739BQ35765577-11D24F6E-28BA-40A9-8C68-1049E19DABB3Q36126718-0D7643D9-4CF7-4C59-8BA8-C699D54923A1Q36316488-19263654-4115-4326-8C47-26D3B6BEB291Q36401431-950BA929-2BA0-43E1-BE26-B8D7A5F99D3AQ36816587-289A91D0-30FF-471E-B1B2-D9FAF44A6B13Q37521050-7D0A9922-64AD-4127-B3FD-057E8788DC97Q45364853-ECB5C9B2-0ED2-4325-A1AB-3CD3B309BD97Q46405577-3A6A1EAB-CEE3-44A2-933A-4B178CF94297Q50044361-454BB5C9-CF00-4CC0-81A4-D25C252C5DD2Q52679598-4D903E71-6E75-4A8C-94D0-90C625B66A65Q55333748-4062C0F0-1DAC-4698-B4FB-341B42D31159
P2860
Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Engineered domain-based assays ...... ns targeting the same protein.
@en
type
label
Engineered domain-based assays ...... ns targeting the same protein.
@en
prefLabel
Engineered domain-based assays ...... ns targeting the same protein.
@en
P2093
P2860
P356
P1476
Engineered domain-based assays ...... ns targeting the same protein.
@en
P2093
C Garcia-Rodriguez
G Manzanarez
J Bettencourt
M A Silberg
P2860
P304
P356
10.1016/J.AB.2012.08.005
P407
P577
2012-08-21T00:00:00Z